Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Repurposing drugs for the treatment of acute GvHD

Shernan Holtan, MD, University of Minnesota, Minneapolis, MN, talks on the growing use of regenerative treatment strategies in acute graft-versus-host disease (aGvHD). A recent Phase II study (NCT02525029) has shown that repurposing existing drugs such as human chorionic gonadotropin represents a promising option to improve the outcomes of patients with GvHD whilst decreasing the cost of treatment. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.